Abstract
A battery of psychometric tests was administered to 85 patients with epilepsy, of whom 26 were untreated, 40 received carbamazepine monotherapy and 19 took carbamazepine with another anticonvulsant. Carbamazepine alone had little effect on performance, but carbamazepine polypharmacy produced significant impairment. Increasing concentrations of carbamazepine (four tests) and its active metabolite, carbamazepine 10,11 epoxide (seven tests), correlated with decreasing performance in the monotherapy patients.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrewes D. G., Bullen J. G., Tomlinson L., Elwes R. D., Reynolds E. H. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia. 1986 Mar-Apr;27(2):128–134. doi: 10.1111/j.1528-1157.1986.tb03515.x. [DOI] [PubMed] [Google Scholar]
- Beran R. G., Flanagan P. J. Psychosocial sequelae of epilepsy: the role of associated cerebral pathology. Epilepsia. 1987 Mar-Apr;28(2):107–110. doi: 10.1111/j.1528-1157.1987.tb03634.x. [DOI] [PubMed] [Google Scholar]
- Brodie M. J., Forrest G., Rapeport W. G. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Br J Clin Pharmacol. 1983 Dec;16(6):747–749. doi: 10.1111/j.1365-2125.1983.tb02257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brodie M. J., McPhail E., Macphee G. J., Larkin J. G., Gray J. M. Psychomotor impairment and anticonvulsant therapy in adult epileptic patients. Eur J Clin Pharmacol. 1987;31(6):655–660. doi: 10.1007/BF00541291. [DOI] [PubMed] [Google Scholar]
- Dodrill C. B. Correlates of generalized tonic-clonic seizures with intellectual, neuropsychological, emotional, and social function in patients with epilepsy. Epilepsia. 1986 Jul-Aug;27(4):399–411. doi: 10.1111/j.1528-1157.1986.tb03559.x. [DOI] [PubMed] [Google Scholar]
- Dodrill C. B., Troupin A. S. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology. 1977 Nov;27(11):1023–1028. doi: 10.1212/wnl.27.11.1023. [DOI] [PubMed] [Google Scholar]
- Fischbacher E. Effect of reduction of anticonvulsants on wellbeing. Br Med J (Clin Res Ed) 1982 Aug 7;285(6339):423–424. doi: 10.1136/bmj.285.6339.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hodgman C. H., McAnarney E. R., Myers G. J., Iker H., McKinney R., Parmelee D., Schuster B., Tutihasi M. Emotional complications of adolescent grand mal epilepsy. J Pediatr. 1979 Aug;95(2):309–312. doi: 10.1016/s0022-3476(79)80680-0. [DOI] [PubMed] [Google Scholar]
- Ludgate J., Keating J., O'Dwyer R., Callaghan N. An improvement in cognitive function following polypharmacy reduction in a group of epileptic patients. Acta Neurol Scand. 1985 Jun;71(6):448–452. doi: 10.1111/j.1600-0404.1985.tb03227.x. [DOI] [PubMed] [Google Scholar]
- MacPhee G. J., Goldie C., Roulston D., Potter L., Agnew E., Laidlaw J., Brodie M. J. Effect of carbamazepine on psychomotor performance in näive subjects. Eur J Clin Pharmacol. 1986;30(1):37–42. doi: 10.1007/BF00614193. [DOI] [PubMed] [Google Scholar]
- Macphee G. J., McPhail E. M., Butler E., Brodie M. J. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients. Eur J Clin Pharmacol. 1986;31(2):195–199. doi: 10.1007/BF00606658. [DOI] [PubMed] [Google Scholar]
- Macphee G. J., Mitchell J. R., Wiseman L., McLellan A. R., Park B. K., McInnes G. T., Brodie M. J. Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man. Br J Clin Pharmacol. 1988 Jan;25(1):59–66. doi: 10.1111/j.1365-2125.1988.tb03282.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKauge L., Tyrer J. H., Eadie M. J. Factors influencing simultaneous concentrations of carbamazepine and its epoxide in plasma. Ther Drug Monit. 1981;3(1):63–70. [PubMed] [Google Scholar]
- Novelly R. A., Schwartz M. M., Mattson R. H., Cramer J. A. Behavioral toxicity associated with antiepileptic drugs: concepts and methods of assessment. Epilepsia. 1986 Jul-Aug;27(4):331–340. doi: 10.1111/j.1528-1157.1986.tb03550.x. [DOI] [PubMed] [Google Scholar]
- POND D. A., BIDWELL B. H. A survey of epilepsy in fourteen general practices. II. Social and psychological aspects. Epilepsia. 1960 Apr;1:285–299. doi: 10.1111/j.1528-1157.1959.tb04266.x. [DOI] [PubMed] [Google Scholar]
- Patsalos P. N., Stephenson T. J., Krishna S., Elyas A. A., Lascelles P. T., Wiles C. M. Side-effects induced by carbamazepine-10,11-epoxide. Lancet. 1985 Aug 31;2(8453):496–496. doi: 10.1016/s0140-6736(85)90420-9. [DOI] [PubMed] [Google Scholar]
- Post R. M., Uhde T. W., Ballenger J. C., Chatterji D. C., Greene R. F., Bunney W. E., Jr Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun;40(6):673–676. doi: 10.1001/archpsyc.1983.04390010083010. [DOI] [PubMed] [Google Scholar]
- Reynolds E. H., Travers R. D. Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report. Br J Psychiatry. 1974 May;124(0):440–445. doi: 10.1192/bjp.124.5.440. [DOI] [PubMed] [Google Scholar]
- Smith D. B., Craft B. R., Collins J., Mattson R. H., Cramer J. A. Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia. 1986 Nov-Dec;27(6):760–768. doi: 10.1111/j.1528-1157.1986.tb03607.x. [DOI] [PubMed] [Google Scholar]
- Thompson P. J., Trimble M. R. Anticonvulsant drugs and cognitive functions. Epilepsia. 1982 Oct;23(5):531–544. doi: 10.1111/j.1528-1157.1982.tb05439.x. [DOI] [PubMed] [Google Scholar]
- Tomson T., Bertilsson L. Potent therapeutic effect of carbamazepine-10,11-epoxide in trigeminal neuralgia. Arch Neurol. 1984 Jun;41(6):598–601. doi: 10.1001/archneur.1984.04210080006004. [DOI] [PubMed] [Google Scholar]
